Microbotox (Mesobotox)

Heavily diluted botulinum toxin (~5-10x dilution from standard Botox concentration) injected intradermally in a grid pattern across treatment area (typically full face, jawline, or neck). Each micro-injection delivers a tiny dose to the dermis. The cumulative effect targets sebaceous glands, sweat glands, and the dermal-epidermal junction without significantly affecting underlying muscle function.

Topical numbing cream applied 20-30 minutes before treatment. Procedure takes 20-40 minutes for full face. Sensation is multiple small needle pricks. Immediate post-treatment: small wheals visible for 30-60 minutes, mild redness for 2-4 hours. No significant downtime.

Standard Botox (botulinum toxin type A) is injected at standard concentration into specific muscle groups (frontalis, corrugator, orbicularis) to relax muscle contractions and reduce expression-line wrinkles. Microbotox is a different application of the same active ingredient: heavily diluted (typically 5-10x dilution from standard), injected at very superficial depth (intradermal rather than intramuscular), in many small doses across a treatment area.

The result targets the skin itself rather than underlying muscle. Microbotox produces:

• Reduced sweat and sebum production at the application site
• Visible pore reduction
• Smoother skin texture
• Mild lifting of jawline and neck
• Subtle reduction of fine surface lines

The technique was popularized in Korean and Asian aesthetic medicine, where the cultural preference is for skincare-class smoothing rather than the more-American expression-line-paralysis approach. It's now common in dermatology and aesthetic clinics globally.

Different from baby botox, which is reduced-dose standard injection technique. Microbotox is a fundamentally different injection strategy — many small superficial doses across an area vs. concentrated deep doses at specific points.